Philip Buffington, MD
Urology · Cincinnati, OHNPI 1114967973
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $717 and has fallen 66.6% since, to $240 in 2025. That places this record below the midpoint for urology clinicians in OH, where the typical reported total is $2,547.
Across 76 payments — averaging $25.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$373
- Boston Scientific$365
- Axonics, Inc.$250
- Calyxo, Inc.$158
- SRS Medical Systems, Inc.$135
- Neotract Inc.$129
- plus $495 from 16 others
What the payments were for
- Food & beverage$1,89499%
- Education$111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 19 | $373 |
| Boston Scientific | 9 | $365 |
| Axonics, Inc. | 13 | $250 |
| Calyxo, Inc. | 1 | $158 |
| SRS Medical Systems, Inc. | 1 | $135 |
| Neotract Inc. | 4 | $129 |
| AbbVie | 5 | $106 |
| Immunitybio, Inc. | 1 | $67 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Dendreon Pharmaceuticals LLC | 2 | $30 |
| Pfizer | 2 | $30 |
| Johnson & Johnson | 2 | $28 |
| Urogen Pharma, Inc. | 2 | $27 |
| Medtronic(2 entities) | 2 | $27 |
| Acerus Pharmaceuticals Corporation | 2 | $25 |
| Endo Pharmaceuticals Inc. | 2 | $25 |
| Coloplast | 2 | $23 |
| Rochester Medical Corporation | 1 | $19 |
| Tolmar Pharmaceuticals, Inc. | 1 | $15 |
| KARL Storz Endoscopy-america | 1 | $14 |
| Antares Pharma, Inc. | 1 | $13 |
| Blue Earth Diagnostics | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,906 in reported general payments places this provider in the 40th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 79 | $168 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $146 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other urology in Cincinnati
- Abhinav SidanaCincinnati$174K
- Paurush BabbarCincinnati$140K
- Marc PliskinCincinnati$108K
- Stephen BennettCincinnati$38K
- Michael RousseauCincinnati$26K
- Kamal PoharCincinnati$20K
- Ryan FlynnCincinnati$16K
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.